Ergomar is a Sublingual Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Rosedale Therapeutics. The primary component is Ergotamine Tartrate.
| Product ID | 10802-1202_6ac058ea-d4f4-4fcd-83e1-5f2adb8652e6 |
| NDC | 10802-1202 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ergomar |
| Generic Name | Ergotamine Tartrate |
| Dosage Form | Tablet, Orally Disintegrating |
| Route of Administration | SUBLINGUAL |
| Marketing Start Date | 2012-08-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA087693 |
| Labeler Name | Rosedale Therapeutics |
| Substance Name | ERGOTAMINE TARTRATE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Ergotamine Derivative [EPC],Ergotamines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2012-08-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA087693 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-08-31 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA087693 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-08-31 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| ERGOTAMINE TARTRATE | 2 mg/1 |
| SPL SET ID: | 1bfd4827-5123-4dbb-8f94-7b097f5bfd5c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10802-1202 | Ergomar | Ergotamine Tartrate |
| 70720-120 | Ergomar | Ergotamine Tartrate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ERGOMAR 77942800 3859849 Live/Registered |
TERSERA THERAPEUTICS LLC 2010-02-23 |
![]() ERGOMAR 75376600 2293362 Dead/Cancelled |
ROSEDALE THERAPEUTICS, LLC 1997-10-21 |
![]() ERGOMAR 72059562 0681389 Dead/Expired |
NORDSON PHARMACEUTICAL LABORATORIES, INC. 1958-09-25 |